1. Medtech Insight
  2. >>Archive

Cook to NGage urology market with launch of kidney stone extractor:

A new kidney stone extractor, NGage, has been launched worldwide by its developer, Cook Medical. NGage is made of Nitinol, a shape-memory alloy of nickel and titanium, and is designed to retain its shape following extreme torsion whilst being flexible enough to allow stone manipulation without damaging the renal tissue. It can secure and grip kidney or ureteral stones firmly, and extract and release them easily. Available in diameters of 1.7 French and 2.2 French, the NGage can entrap stone fragments as small as 1mm. A spokesperson for Bloomington, Indiana-based Cook said that the device "went down a storm at the recent annual meeting of the European Association of Urologists", and is now available in the US and the UK. It was CE marked for sale in Europe and cleared for sale in the US in 2007.

A new kidney stone extractor, NGage, has been launched worldwide by its developer, Cook Medical. NGage is made of Nitinol, a shape-memory alloy of nickel and titanium, and is designed to retain its shape following extreme torsion whilst being flexible enough to allow stone manipulation without damaging the renal tissue. It can secure and grip kidney or ureteral stones firmly, and extract and release them easily. Available in diameters of 1.7 French and 2.2 French, the NGage can entrap stone fragments as small as 1mm. A spokesperson for Bloomington, Indiana-based Cook said that the device "went down a storm at the recent annual meeting of the European Association of Urologists", and is now available in the US and the UK. It was CE marked for sale in Europe and cleared for sale in the US in 2007.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

Final Chance To Have Your Say: Take Our Reader Survey This Week

 
• By Ryan Nelson

Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.

Shape Our Content: Take The Reader Survey

 
• By Ryan Nelson

Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.

Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS

 
• By Marion Webb

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

Podcast: Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic

 
• By Natasha Barrow

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

More from Medtech Insight

Three Steps To Investor Heaven For Medtech Founders: Articulate, Explain, Clarify

 
• By Ashley Yeo

Capital remains available for good healthtech projects, but it is more concentrated and harder to find than of late. Founders and inventors must know how to unlock it. The BioWales 2025 investor panel told them where they could be going wrong.

Aneira Health Launches New Precision Medicine Platform Exclusively For Women

 
• By Natasha Barrow

Cecilia Lindgren, Aneira Health’s co-founder and chief science officer, said that the company has “redesigned the diagnostic model.” The subscription-based platform offers clinical-grade and AI diagnostics alongside clinical consultation.

AI In Health Delivery: Patients Most Confident When HCPs Are In Charge

 
• By Ashley Yeo

Annual survey of patients and professionals shows how attitudes to health system transformation are evolving and what stakeholders are demanding as acceptance of AI tools accelerates.